Table 1 Baseline characteristics of patients with different T-stage gastric cancer
From: The prognostic role of tumor size in stage T1 gastric cancer
All (%) | T1 (%) | T2 (%) | T3 (%) | T4 (%) | |
|---|---|---|---|---|---|
Age, years | |||||
≤65 | 2464 (41.4) | 460 (33.5) | 295 (40.5) | 824 (42.7) | 885 (46.0) |
>65 | 3489 (58.6) | 913 (66.5) | 433 (59.5) | 1106 (57.3) | 1037 (53.9) |
Sex | |||||
Feman | 2567 (43.1) | 629 (45.8) | 306 (42.0) | 744 (38.5) | 888 (46.2) |
Man | 3386 (56.9) | 744 (54.2) | 422 (58.0) | 1186 (61.4) | 1034 (53.8) |
Grade | |||||
I | 309 (5.2) | 201 (14.6) | 31 (4.3) | 49 (2.5) | 28 (1.5) |
II | 1482 (24.9) | 466 (33.9) | 232 (31.9) | 485 (25.1) | 299 (15.5) |
III | 4000 (67.24) | 679 (49.5) | 444 (61.0) | 1339 (69.3) | 1538 (80.0) |
IV | 162 (2.7) | 27 (2.0) | 21 (2.9) | 57 (3.0) | 57 (3.0) |
N stage | |||||
N0 | 2366 (39.7) | 1111 (80.9) | 398 (54.7) | 554 (28.7) | 303 (15.8) |
N1 | 1086 (18.2) | 156 (11.4) | 162 (22.3) | 442 (22.9) | 326 (17.0) |
N2 | 1023 (17.2) | 77 (5.6) | 101 (13.9) | 427 (22.1) | 418 (21.7) |
N3 | 1478 (24.8) | 29 (2.1) | 67 (9.2) | 507 (26.3) | 875 (45.5) |
M stage | |||||
M0 | 5315 (89.3) | 1347 (98.1) | 705 (96.8) | 1749 (90.6) | 1514 (78.7) |
M1 | 638 (10.7) | 26 (1.9) | 23 (3.2) | 181 (9.4) | 408 (21.2) |
Race | |||||
Black | 973 (16.3 | 218(15.9) | 118 (16.2) | 353 (18.3) | 284 (14.8) |
Other | 1610 (27.0 | 464 (33.8) | 201 (27.6) | 460 (23.8) | 485 (25.2) |
White | 3370 (56.6 | 691 (50.3) | 409 (56.2) | 1117 (57.8) | 11,537 (60.0) |
Tumor size (cm) Median (IQR) | 5.1 (2.5–6.5) | 2.4 (1.0–3.1) | 3.8 (2.2–5.0) | 5.6 (3.5–7.0) | 6.9 (4.0–8.5) |